Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare Conference
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) announced that CEO Brian Markison and CFO Andrew Einhorn will present at the 2020 Jefferies Virtual London Healthcare Conference on November 18, 2020, at 11:25 a.m. Eastern Time. The presentation will be accessible via a live webcast, which will be archived for 30 days afterward. Osmotica is a biopharmaceutical company focused on developing specialty products for underserved markets, with a portfolio that includes various proprietary drug delivery systems and subsidiaries such as RVL Pharmaceuticals.
- None.
- None.
BRIDGEWATER, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 2020 Jefferies Virtual London Healthcare Conference as follows:
| Date: | Wednesday, November 18, 2020 |
| Time: | 11:25 a.m. Eastern Time |
| Webcast: | https://wsw.com/webcast/jeff141/osmt/1873875 |
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.osmotica.com under the “Investor & News” section.
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting Upneeq. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the Company’s non-promoted products, including complex generic formulations.
Osmotica has operations in the United States, Argentina, and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
When will Osmotica Pharmaceuticals present at the Jefferies Virtual London Healthcare Conference?
Where can I watch the Osmotica Pharmaceuticals conference presentation?
What time is Osmotica Pharmaceuticals' presentation at the conference?
What is Osmotica Pharmaceuticals focused on?
What subsidiaries does Osmotica Pharmaceuticals have?
